Provista Diagnostics researchers say the company's Videssa® Breast test can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce the use of traditional biopsy by up to 67%. (Source: [iStock/David Marchal)

Sequencing Method that Maps Breast Cell Differentiation Provides Insight to Cancer Development

Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific...

Novartis Solicits Proposals to Advance Biomarker Testing in Cancer

Novartis is soliciting proposals from patient advocacy organizations for initiatives designed to expand and improve understanding of biomarker testing among people with cancer that...
Next-Generation Sequencing Test for Cutaneous Melanoma

Single-Cell Transcriptional Analysis Predicts Melanoma Drug Response

Investigators at the Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have just released findings from a new study...
digital dna

Artificial Intelligence Enhances Oncology

The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
Invitae lab

Search and Detect (for Free): Invitae Pursues Sponsors for Free Genetic Testing Programs Targeting...

Among the challenges long faced by diagnostics developers striving to broaden the use of their tests is finding enough patients to generate enough samples,...
With NGS diagnostics

Illumina and Qiagen Enter 15-Year Diagnostics Partnership

Two leaders in genomics and molecular analysis, Illumina and QIAGEN, have announced a 15-year partnership that the companies say is aimed at increasing the...
Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]

NIH Commits $38M to Rare Disease Research and Affiliated Data Center

About $31 million in grants has been awarded by The National Institutes of Health in fiscal year 2019 to 20 teams in order to...
Stomach Ache Problem

Takeda, Prometheus Enter IBD Drug-Companion Diagnostic Partnership

Prometheus Biosciences said its bioinformatics platform and advanced machine learning techniques will be used by Takeda Pharmaceutical as part of a global collaboration to...
These cramps are getting worse now

Gut Immune Cell Clock Genes Disruption Linked to IBD, Immune Control

Two independent sets of research published in Science Immunology have demonstrated how a subset of immune cells in the gut, known as group 3...
Verge Genomics has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. [Source: kentoh/Getty Images]

Novartis, with Assist from Microsoft, Launches AI Innovation Lab

Novartis will establish an “AI innovation lab” designed to enable its research and commercial employees to use Microsoft’s artificial intelligence solutions across operations, with...
Scroll Up